Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01497405 · ClinicalTrials.gov registry record · Phase 1
WHC+ (Women's Health CoOp PLUS)
A Phase 1 study, sponsored by RTI International.
- Completed
- Registry status
- Phase 1
- Development phase
- 641
- Enrollment target
NCT01497405: Completed Phase 1 study, sponsored by RTI International.
NCT01497405 is a Phase 1 study that has completed, run by RTI International. The registered enrollment target is 641 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (968% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01497405, a Phase 1 study, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 641 participants
- Enrollment target
Study Summary
This study compares the effects of standard HIV test, treat and retain (TTR) practices with TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention) targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine if the WHC+ intervention is more efficacious than TTR alone in reducing HIV risk behavior. Additionally, the study will determine whether HIV positive women in the WHC+ arm are more likely to follow through with referrals for further medical evaluation and linkages to HIV treatment and other care than women in the TTR arm.
Primary Outcome
Percentages of condom use at last sex
Interventions
- BEHAVIORAL Test, Treat, Retain(TTR) + Women's Health CoOp (WHC)
- BIOLOGICAL Test, Treat, Retain(TTR) only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 641 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
What the finished NCT01497405 record still lists
NCT01497405 is an interventional study that assigns participants to a tested intervention. The registered 641 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (968% higher).
The record links to 0 conditions, and to 2 interventions - of which Test, Treat, Retain(TTR) + Women's Health CoOp (WHC) is the first listed.
NCT01497405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01497405 about?
NCT01497405 is a clinical study titled "WHC+ (Women's Health CoOp PLUS)". This study compares the effects of standard HIV test, treat and retain (TTR) practices with TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention) targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine if the WHC+ intervention is mo...
What is the current status of trial NCT01497405?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 641 participants. The study started on 2012-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01497405?
The interventions under investigation include: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC) (BEHAVIORAL), Test, Treat, Retain(TTR) only (BIOLOGICAL).
Who is sponsoring clinical trial NCT01497405?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01497405's enrollment target sits among peer trials
641 22nd of 2000 higher than 1,979 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06319820 · 641 participants · Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- NCT06625060 · 641 participants · Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia